Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Plantation

2 abstracts

Abstract
Co-occurrence of ESR1 and PIK3CA mutations in HR+/HER2- metastatic breast cancer: Incidence and outcomes with targeted therapy.
Org: Plantation, Fort Lauderdale,
Abstract
Incidence and outcomes among patients with HR+/HER2- metastatic breast cancer (mBC) with co-occurring ESR1 and PIK3CA mutations detected by ctDNA and treated with alpelisib: A retrospective review.
Org: Miami Cancer Institute - Baptist Health South Florida, Baptist Health South Florida, Flare Therapeutics, Plantation, Guardant Health, Inc.,